Barbara Goldstein, MD
Rheumatology · Denver, CONPI 1285885095
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,353 of the $47,303 with a category attached, or 70.5%. 36 manufacturers reported payments, led by GSK at 35.4% of the total. Among rheumatology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $110.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$17K
- Regeneron Healthcare Solutions, Inc.$10K
- AbbVie$8K
- Pfizer$5K
- AstraZeneca$4K
- Amgen$684
- plus $3K from 30 others
What the payments were for
- Consulting fees$3,3507%
- Speaking & faculty fees$33,35371%
- Travel & lodging$2,5195%
- Food & beverage$7,95317%
- Education$1290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 67 | $16,752 |
| Regeneron Healthcare Solutions, Inc. | 28 | $10,268 |
| AbbVie | 61 | $7,902 |
| Pfizer | 51 | $5,271 |
| AstraZeneca | 30 | $3,502 |
| Amgen(2 entities) | 34 | $684 |
| UCB, Inc. | 29 | $486 |
| Novartis | 29 | $425 |
| Organon | 16 | $279 |
| Genentech USA, Inc. | 12 | $213 |
| Radius Health, Inc. | 10 | $190 |
| Lilly USA, LLC | 8 | $164 |
| Sobi, Inc | 6 | $161 |
| Aurinia Pharma U.S., Inc. | 5 | $123 |
| Johnson & Johnson | 7 | $119 |
| Sanofi | 7 | $114 |
| Cardinal Health 110 LLC | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 5 | $91 |
| Genentech, Inc. | 1 | $50 |
| Antares Pharma, Inc. | 3 | $45 |
| Alvogen Inc | 2 | $40 |
| Sandoz | 2 | $33 |
| Celltrion USA Inc. | 1 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Invivyd Inc | 1 | $29 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,303 in reported general payments places this provider in the 90th percentile of 108 rheumatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 20 | $154,359 |
| Humira(Cf) PenAdalimumab | 21 | $142,827 |
| Orencia ClickjectAbatacept | 11 | $63,166 |
| Hydroxychloroquine Sulfate | 110 | $6,581 |
| MethotrexateMethotrexate Sodium | 187 | $5,489 |
| Celecoxib | 50 | $3,316 |
| Leflunomide | 47 | $2,607 |
| Cevimeline Hcl | 13 | $2,348 |
| Pregabalin | 32 | $1,642 |
| Prednisone | 176 | $1,619 |
| Duloxetine Hcl | 41 | $1,406 |
| Sulfasalazine | 40 | $1,244 |
| Alendronate Sodium | 124 | $830 |
| Gabapentin | 33 | $777 |
| Allopurinol | 68 | $724 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Denver
- Aryeh FischerDenver$114K
- Adam BerlinbergDenver$94K
- Rennie McCabeDenver$58K
- Christopher AntoliniDenver$34K
- Mehrnaz Maleki FischbachDenver$25K
- Liudmila KastsianokDenver$22K
- David KormanDenver$20K
- Kathleen SrockDenver$19K
- Mary DemoruelleDenver$12K
- Leslie RoseDenver$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.